Pneumococcal Vaccine in Patients with Systemic Juvenile Idiopathic Arthritis Receiving Biologic Therapy: International Practice Review | Zendy

Е. И. Алексеева | Zendy; D. Vankova | Zendy; Margarita А. Soloshenko | Zendy; T.M. Dvoryakovskaya | Zendy; К. Б. Исаева | Zendy; Р.В. Денисова | Zendy; A. Mamutova | Zendy; Aleksandra M. Chomahidze | Zendy; Nikolay Mayanskiy | Zendy; Н. Е. Ткаченко | Zendy

Open Access

Pneumococcal Vaccine in Patients with Systemic Juvenile Idiopathic Arthritis Receiving Biologic Therapy: International Practice Review

Author(s) -

Е. И. Алексеева,

D. Vankova,

Margarita А. Soloshenko,

T.M. Dvoryakovskaya,

К. Б. Исаева,

Р.В. Денисова,

A. Mamutova,

Aleksandra M. Chomahidze,

Nikolay Mayanskiy,

Н. Е. Ткаченко

Publication year - 2019

Publication title -

вопросы современной педиатрии

Language(s) - English

Resource type - Journals

eISSN - 1682-5535

pISSN - 1682-5527

DOI - 10.15690/vsp.v18i2.2012

Subject(s) - medicine , arthritis , vaccination , pneumococcal disease , immunization , immunology , pneumococcal vaccine , disease , intensive care medicine , immune system , streptococcus pneumoniae , antibiotics , microbiology and biotechnology , biology

International practice of immunization against pneumococcus in patients with systemic juvenile idiopathic arthritis (SJIA) receiving biological therapy is generalized in this review. High efficiency and safety of pneumococcal vaccines in children with SJIA is presented. Numerous researches show the adequate immune response after vaccination as well as alongside with genetically engineered biologic drugs therapy. Prevention of pneumococcal disease in patients with SJIA reduces the risk of development of pneumococcal diseases severe complications.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research